On the other hand, despite the beneficial actions of GH treatment in the CNS, some concern still remains about the potential risk of promoting malignant tumors, diabetes, or angiogenesis-related diseases, which underscores the need for further studies to establish its dosing and long-term safety [68]. Here, GH1 is linked to diabetes mellitus.